PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 June; 8(2): E94–E101.
Published online 2007 May 24. doi:  10.1208/pt0802039
PMCID: PMC2750378

Chitosan film containing fucoidan as a wound dressing for dermal burn healing: Preparation and in vitro/in vivo evaluation

Abstract

The aim of this study was to develop chitosan film containing fucoidan and to investigate its suitability for the treatment of dermal burns on rabbits. Porous films, thickness between 29.7 and 269.0 μm, were obtained by the solvent dropping method. Water vapor permeability (3.3–16.6/0.1 g), the swelling (0.67–1.77 g/g), tensile strength (7.1–45.8 N), and bioadhesion (0.076–1.771 mJ/cm2) of the films were determined. The thinnest films were obtained with the lowest chitosan concentration (P<.05). The water absorption capacity of the films sharply increased with the freeze-drying technique. The film having the thickness of 29.7 μm showed the highest amount of moisture permeability (16.6 g/0.1 g). Higher chitosan concentration significantly increased tensile strength of the films (P<.05). Using higher concentration of lactic acid made films more elastic and applicable, and these films were selected for in vivo studies. Seven adult male New Zealand white rabbits were used for the evaluation of the films on superficial dermal burns. Biopsy samples were taken at 7, 14, and 21 days after wounding, and each wound site was examined macroscopically and histopathologically. After 7 days treatment, fibroplasia and scar were observed on wounds treated with fucoidan-chitosan film. The best regenerated dermal papillary formation, best reepithelization, and the fastest closure of wounds were found in the fucoidan-chitosan film treatment group after 14 days compared with other treatment and control groups. It can be concluded that fucoidan-chitosan films might be a potential treatment system for dermal burns and that changing formulation variables can modulate the characterizations of the films.

Keywords: Fucoidan, chitosan, biopolymer, film, wound healing

Full Text

The Full Text of this article is available as a PDF (354K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg. 2004;187:S11–S16. doi: 10.1016/S0002-9610(03)00296-4. [PubMed] [Cross Ref]
2. Shakespeare P. Burn wound healing and skin substitutes. Burns. 2001;27:517–522. doi: 10.1016/S0305-4179(01)00017-1. [PubMed] [Cross Ref]
3. Lloyd LL, Kennedy JF, Methacanon P, Paterson M, Knill CJ. Carbohydrate polymers as wound management aids. Carbohydr Polym. 1998;37:315–322. doi: 10.1016/S0144-8617(98)00077-0. [Cross Ref]
4. Alemdaroğlu C, Değim Z, Çelebi N, Zor F, Öztürk S, Erdoğan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns. 2006;32:319–327. doi: 10.1016/j.burns.2005.10.015. [PubMed] [Cross Ref]
5. Ueno H, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes. Biomaterials. 2001;22:1667–1673. doi: 10.1016/S0142-9612(00)00328-8. [PubMed] [Cross Ref]
6. Pereira M, Mulloy B, Mourao PAS. Structure and anticoagulant activity of sulfated fucans. J Biol Chem. 1999;274:7656–7667. doi: 10.1074/jbc.274.12.7656. [PubMed] [Cross Ref]
7. Fujimura T, Shibuya Y, Moriwaki S, et al. Fucoidan is the active component of fucus vesiculosus that promotes contraction of fibroblast-populated collagen gels. Biol Pharm Bull. 2000;23:1180–1184. [PubMed]
8. O'Leary R, Rerek M, Wood EJ. Fucoidan modulates the effect of transforming growth factor (TGF)-β1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair. Biol Pharm Bull. 2004;27:266–270. doi: 10.1248/bpb.27.266. [PubMed] [Cross Ref]
9. Sezer AD, Cevher E, Akbuğa J. In vitro characterization of chitosan films containing fucoidan. Paper presented at: 12th International Pharmaceutical Technology Symposium; September 13–15, 2004; Istanbul, Turkey.
10. Remuñán-López C, Bodmeier R. Mechanical water uptake and permeability of crosslinked chitosan glutamate and alginate films. J Control Release. 1997;44:215–225. doi: 10.1016/S0168-3659(96)01525-8. [Cross Ref]
11. Shu XZ, Zhu KJ, Weihong S. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. Int J Pharm. 2001;212:19–28. doi: 10.1016/S0378-5173(00)00582-2. [PubMed] [Cross Ref]
12. Kalapathy U, Proctor A, Shultz J. Production and properties of flexible sodium silicate films from rice hull ash silica. Bioresour Technol. 2000;72:99–106. doi: 10.1016/S0960-8524(99)00112-1. [Cross Ref]
13. Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 1999;178:11–22. doi: 10.1016/S0378-5173(98)00342-1. [PubMed] [Cross Ref]
14. Knabl JS, Bauer W, Andel H, et al. Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model. Burns. 1999;25:715–721. doi: 10.1016/S0305-4179(99)00086-8. [PubMed] [Cross Ref]
15. Derenzini M. The AgNORs. Micron. 2000;31:117–120. doi: 10.1016/S0968-4328(99)00067-0. [PubMed] [Cross Ref]
16. Trere D. AgNOR staining and quantification. Micron. 2000;31:127–131. doi: 10.1016/S0968-4328(99)00069-4. [PubMed] [Cross Ref]
17. Berthod F, Saintigny G, Chretien F, Hayek D, Collombel C, Damour O. Optimization of thickness, pore size and mechanical properties of a biomaterial designed for deep burn coverage. Clin Mater. 1994;15:259–265. doi: 10.1016/0267-6605(94)90055-8. [PubMed] [Cross Ref]
18. Khan T, Peh K, Ch'ng H. Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing. J Pharm Pharm Sci. 2000;3:303–311. [PubMed]
19. Bangyekan C, Duangdao AO, Srikulkit K. Preparation and properties evaluation of chitosan-coated cassava starch films. Carbohydr Polym. 2006;63:61–71. doi: 10.1016/j.carbpol.2005.07.032. [Cross Ref]
20. Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm. 1996;145:231–240. doi: 10.1016/S0378-5173(96)04776-X. [Cross Ref]
21. Ishihara M, Nakanishia K, Ono K, et al. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials. 2002;23:833–840. doi: 10.1016/S0142-9612(01)00189-2. [PubMed] [Cross Ref]
22. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57:1556–1568. doi: 10.1016/j.addr.2005.07.001. [PubMed] [Cross Ref]
23. Ueno H, Mori T, Fujinaga T. Topical formulation and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52:105–115. doi: 10.1016/S0169-409X(01)00189-2. [PubMed] [Cross Ref]
24. Hideyuki S, Masato N, Toshiko K, Haruji S, Hidesuke H, Terou Y, inventors. Complex of fibroblast growth factor. Japan Patent (JP) application no.: JP/1996/10017498. January 20, 1998.
25. Provenzano PP, Alejandro-Osorio AL, Valhmu WB, Jensen KT, Vanderby R. Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo. Matrix Biol. 2005;23:543–555. doi: 10.1016/j.matbio.2004.09.008. [PubMed] [Cross Ref]
26. Eichler MJ, Carlson MA. Modeling dermal granulation tissue with the linear fibroblast-populated collagen matrix: a comparison with the round matrix model. J Dermatol Sci. 2006;41:97–108. doi: 10.1016/j.jdermsci.2005.09.002. [PubMed] [Cross Ref]
27. Erdağ G, Sheridan RL. Fibroblasts improve performance of cultured composite skin substitutes on athymic mice. Burns. 2004;30:322–328. doi: 10.1016/j.burns.2003.12.007. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists